Keyphrases
Adenine Base Editor
15%
APOBEC
18%
ATPase Subunits
18%
Base Editor
60%
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
16%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
79%
Code of Ethics
18%
CRISPR Base Editor
18%
Cytidine Deaminase
14%
Cytosine
24%
Cytosine Base Editor
34%
DNA Editing
12%
DNA Sequencing
48%
Editing Activity
21%
Electric
18%
Extracellular pH
18%
Focal Segmental Glomerulosclerosis
18%
Frizzled
18%
G Protein-coupled Receptor Signaling
12%
G-base
18%
Gene Drive
18%
Gene Editing
18%
Genome Editing
23%
GFR Estimation
18%
Guide RNA (gRNA)
26%
Human Cells
35%
Human Disease
18%
Human Keratinocytes (HaCaT)
18%
Lenalidomide
18%
Minimal Change Disease
18%
Moloney murine Leukemia Virus
12%
Multiple Myeloma Patients
18%
Nephrotic Syndrome
18%
Neutral pH
12%
Planar Polarity
18%
Prime Editing
24%
Prime Editor
18%
Prospective Cohort Study
18%
Purinergic Signaling
18%
Rapid Design
18%
Reverse Transcriptase
18%
RNA Editing
42%
Self-editing
18%
Simplified Design Method
18%
Target DNA
15%
Target RNA
28%
Transcriptome-wide
23%
Transversion
18%
Untethered
18%
Vacuolar H+-ATPase (V-ATPase)
18%
Biochemistry, Genetics and Molecular Biology
Adenine
34%
APOBEC1
20%
AT Rich Sequence
9%
C-Terminus
6%
Cas9
19%
Cell Polarity
8%
CRISPR
100%
Cytidine Deaminase
16%
Cytosine
50%
Frizzled
18%
G Protein Coupled Receptor
18%
Gene Drive
18%
Genetic Divergence
6%
Genome Editing
6%
Guide RNA
24%
Human Genetics
6%
Indel
18%
Keratinocyte
18%
Moloney Murine Leukemia Virus
12%
Mutagenesis
6%
Nuclease
6%
Protein Function
6%
Reverse Transcriptase
18%
RNA
56%
RNA Editing
33%
Streptococcus pyogenes
9%
Transcriptome
22%
Transversion
18%
Uracil-DNA Glycosylase
18%
V-ATPase
18%
Medicine and Dentistry
Adenine
23%
Base
32%
Clustered Regularly Interspaced Short Palindromic Repeat
37%
Cooperation
18%
Cytidine Deaminase
9%
Cytosine
23%
Deaminase
18%
Diseases
25%
DNA Base
18%
Focal Segmental Glomerulosclerosis
18%
G Protein Coupled Receptor
18%
Gene Drive
18%
Genome Editing
18%
Glomerular Filtration Rate
9%
Keratinocyte
18%
Kidney Function
10%
Lenalidomide
18%
Minimal Change Disease
18%
Multiple Myeloma
18%
Myeloma
7%
Nephrotic Syndrome
18%
Prospective Cohort Study
18%
RNA Editing
18%
